1194373-75-5

Upstream product

• 19056-40-7 4-bromo-3-methoxyaniline 
• 1041853-01-3 tert-butyl 4-(3-aminocarbonyl-4-(2-fluoro-4-methylphenylamino)-7-methoxycinnolin-6-yl)-3,6-dihydropyridine-1(2H)-carboxylate 
• 1041853-00-2 4-[(2-fluoro-4-methylphenyl)amino]-7-methoxy-6-(1,2,3,6-tetrahydropyridin-4-yl)cinnoline-3-carboxamide 
• 1041853-21-7 6-bromo-4-hydroxy-7-methoxycinnoline-3-carboxylic acid 
• 1041853-18-2 4-amino-6-bromo-7-methoxycinnoline-3-carboxamide 
• 1041853-24-0 6-bromo-4-chloro-7-methoxycinnoline-3-carboxamide 
• 1041852-99-6 4-(2-fluoro-4-methylphenylamino)-7-methoxy-6-(piperidin-4-yl)cinnoline-3-carboxamide 
• 74427-22-8 2,2-difluoroethyl triflate 

Relevant academic research and scientific papers

CHEMICAL COMPOUNDS

The invention relates to chemical compounds of formula (I): or pharmaceutically acceptable salts thereof which possess CSF-IR kinase inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm-blooded animal such as man.